Search results for "AMyloid"

showing 10 items of 494 documents

Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer’s disease

2017

Alzheimer’s disease is a major neurodegenerative disorder that leads to severe cognitive deficits in the elderly population. Over the past two decades, multiple studies have focused on elucidating the causative factors underlying memory defects in Alzheimer’s patients. In this regard, new evidence linking Alzheimer’s disease-related pathology and neuronal stem cells suggests that hippocampal neurogenesis impairment is an important factor underlying these cognitive deficits. However, because of conflicting results, the impact of Aβ pathology on neurogenesis/gliogenesis remains unclear. Here, we investigated the effect of Aβ on neuronal and glial proliferation by using an APP/PS1 transgenic m…

Doublecortin Domain ProteinsMale0301 basic medicineCellular pathologyPathologymedicine.medical_specialtyNeurogenesisGene ExpressionHippocampuslcsh:MedicineMice TransgenicBiologyHippocampusArticleAmyloid beta-Protein PrecursorMice03 medical and health sciences0302 clinical medicineNeural Stem CellsAlzheimer DiseaseSpheroids CellularNeurospheremedicineAnimalsHumansProgenitor celllcsh:ScienceCells CulturedCell ProliferationGliogenesisNeuronsAmyloid beta-PeptidesMultidisciplinaryNeuropeptidesNeurogenesislcsh:RCell DifferentiationNeural stem cellDisease Models Animal030104 developmental biologynervous systemOrgan Specificitylcsh:QStem cellMicrotubule-Associated ProteinsNeurogliaNeuroscience030217 neurology & neurosurgery
researchProduct

Polymer-doxycycline conjugates as fibril disrupters: an approach towards the treatment of a rare amyloidotic disease.

2014

The term amyloidosis describes neurological diseases where an abnormal protein is misfolded and accumulated as deposits in organs and tissues, known as amyloid, disrupting their normal function. In the most common familial amyloid polyneuropathy (FAP), transthyretin (TTR) displays this role primarily affecting the peripheral nervous system (PNS). Advanced stages of this inherited rare amyloidosis, present as fibril deposits that are responsible for disease progression. In order to stop disease progression, herein we designed an efficient family of nanoconjugates as fibril disrupters. These polymer conjugates are based on doxycycline (doxy), already in phase II trials for Alzheimer's disease…

DrugAmyloidErythrocytesAmyloidmedia_common.quotation_subjectPharmaceutical ScienceMice TransgenicFibrilHemolysisPlasmaIn vivomedicinePolymeric drugAnimalsTissue DistributionAmyloid disruptersmedia_commonDoxycyclineAmyloid Neuropathies FamilialMice Inbred BALB CbiologyChemistryAmyloidosismedicine.diseaseRare diseasesRatsTransthyretinPolymer-drug conjugateDisease Models AnimalDrug LiberationBiochemistryPolyglutamic AcidDoxycyclineDrug deliveryDrug deliverybiology.proteinCancer researchPolymer therapeuticsmedicine.drugJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Conical nanopores highlight the pro-aggregating effects of pyrimethanil fungicide on Aβ(1-42) peptides and dimeric splitting phenomena.

2022

International audience; The Aβ(1-42) aggregation is a key event in the physiopathology of Alzheimer's disease (AD). Exogenous factors such as environmental pollutants, and more particularly pesticides, can corrupt Aβ(1-42) assembly and could influence the occurrence and pathophysiology of AD. However, pesticide involvement in the early stages of Aβ(1-42) aggregation is still unknown. Here, we employed conical track-etched nanopore in order to analyse the Aβ(1-42) fibril formation in the presence of pyrimethanil, a widely used fungicide belonging to the anilinopyrimidine class. Our results evidenced a pro-aggregating effect of pyrimethanil on Aβ(1-42). Aβ(1-42) assemblies were successfully d…

Environmental EngineeringAmyloidHealth Toxicology and MutagenesisDimerSettore ING-IND/06track-etchedMolecular dynamicschemistry.chemical_compoundNanoporesFibril formationPEG ratio[CHIM] Chemical SciencesfungicideEnvironmental Chemistry[CHIM]Chemical SciencesnanoporeAmyloid beta-PeptidesChemistryPublic Health Environmental and Occupational HealthamyloidGeneral MedicineGeneral ChemistryPollutionresistive pulsePeptide FragmentsAβ(1-42)Fungicides IndustrialNanoporePyrimidinesAβ(1–42)Biophysicslag phasePyrimethanilChemosphere
researchProduct

Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

2004

Increased Abeta42 production has been linked to the development of Alzheimer disease. We now identify a number of compounds that raise Abeta42. Among the more potent Abeta42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID. Many COX-2-selective NSAIDs tested raised Abeta42, including multiple COX-2-selective derivatives of two Abeta42-lowering NSAIDs. Compounds devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Abeta42. These compounds seem to target the gamma-secretase complex, increasing gamma-secretase-catalyzed production of Abeta42 in vitro. Short-term in vivo studies show that two Abeta42-raising comp…

Enzyme-Linked Immunosorbent AssayEndogenyProtein Serine-Threonine KinasesPharmacologyTransfectionMass SpectrometryGeneral Biochemistry Genetics and Molecular BiologyPresenilinCell LineFenofibrateAlzheimer DiseaseIn vivoEndopeptidasesmedicineAspartic Acid EndopeptidasesHumansImmunoprecipitationCyclooxygenase InhibitorsProtein precursorHypolipidemic AgentsSulfonamidesrho-Associated KinasesAmyloid beta-PeptidesFenofibratebusiness.industryAnti-Inflammatory Agents Non-SteroidalIntracellular Signaling Peptides and ProteinsBrainGeneral Medicinemedicine.diseaseIn vitroEnzyme ActivationBiochemistryCelecoxibPyrazolesFemaleAmyloid Precursor Protein SecretasesAlzheimer's diseaserhoA GTP-Binding ProteinbusinessAntilipidemic Agentmedicine.drugNature Medicine
researchProduct

O3‐10‐05: ROBUST MOLECULAR PROPERTIES UNDERLYING REGIONAL VULNERABILITY TO AMYLOID DEPOSITION AND NEURODEGENERATION IN ALZHEIMER'S DISEASE

2018

EpidemiologyHealth PolicyNeurodegenerationVulnerabilityDiseaseBiologymedicine.diseasePsychiatry and Mental healthCellular and Molecular NeuroscienceAmyloid depositionDevelopmental NeurosciencemedicineNeurology (clinical)Geriatrics and GerontologyNeuroscienceAlzheimer's & Dementia
researchProduct

Phasor FLIM analysis of Thioflavin T fluorescence in protein amyloid aggregates: Mapping molecular interactions.

Thioflavin T (ThT) is a worldwide used dye to monitor protein aggregation as it stains with a certain specificity amyloid structures. The interactions between ThT and its hosts are largely studied suggesting that fluorescence properties of this dye critically depend both on the environment rigidity, electrostatic and hydrophobic properties as well as on molecular details binding site structure. Here FLIM and phasor approach analysis are used to exploit ThT amyloid interactions and, in turn, to address polymorphism and structural heterogeneity of amyloid species mapping aggregate-to-aggregate structural differences and revealing details of molecular architecture within the same aggregate.

FLIMprotein aggregateThioflavin Tphasor amyloidSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)
researchProduct

Effects of confinement on insulin amyloid fibrils formation.

2006

Insulin, a 51-residue protein universally used in diabetes treatment, is known to produce amyloid fibrils at high temperature and acidic conditions. As for other amyloidogenic proteins, the mechanisms leading to nucleation and growth of insulin fibrils are still poorly understood. We here report a study of the fibrillation process for insulin confined in a suitable polymeric hydrogel, with the aim of ascertain the effects of a reduced protein mobility on the various phases of the process. The results indicate that, with respect to standard aqueous solutions, the fibrillation process is considerably slowed down at moderately high concentrations and entirely suppressed at low concentration. M…

FibrillationAmyloidAqueous solutionAdverse conditionsChemistryInsulinmedicine.medical_treatmentDiffusionTemperatureBiophysicsNucleationmacromolecular substancesGeneral MedicineHydrogen-Ion ConcentrationFibrilAmyloid fibrilHydrogel Polyethylene Glycol DimethacrylateBiochemistryPolyvinyl AlcoholmedicineBiophysicsAnimalsInsulinCattlemedicine.symptom
researchProduct

Expression of the Anti-amyloidogenic Secretase ADAM10 Is Suppressed by Its 5′-Untranslated Region*

2010

Proteolytic processing of the amyloid precursor protein by alpha-secretase prevents formation of the amyloid beta-peptide (Abeta), which is the main constituent of amyloid plaques in brains of Alzheimer disease (AD) patients. alpha-Secretase activity is decreased in AD, and overexpression of the alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) in an AD animal model prevents amyloid pathology. ADAM10 has a 444-nucleotide-long, very GC-rich 5'-untranslated region (5'-UTR) with two upstream open reading frames. Because similar properties of 5'-UTRs are found in transcripts of many genes, which are regulated by translational control mechanisms, we asked whether ADAM10 expression is…

Five prime untranslated regionenzymology [Brain]ADAM10ADAM10 protein humanBACE1-ASgenetics [Amyloid Precursor Protein Secretases]genetics [Alzheimer Disease]genetics [ADAM Proteins]BiochemistryGene Expression Regulation Enzymologicbiosynthesis [Membrane Proteins]ADAM10 ProteinAlzheimer DiseaseChlorocebus aethiopsAmyloid precursor proteinProtein biosynthesisbiosynthesis [Amyloid beta-Peptides]genetics [Amyloid beta-Peptides]AnimalsHumansGene RegulationMolecular BiologySequence Deletionbiosynthesis [ADAM Proteins]Amyloid beta-PeptidesbiologyBase SequenceP3 peptideenzymology [Alzheimer Disease]BrainMembrane ProteinsCell BiologyMolecular biologyBiochemistry of Alzheimer's diseasegenetics [Membrane Proteins]ADAM Proteinsbiosynthesis [Amyloid Precursor Protein Secretases]Protein Biosynthesisddc:540COS Cellsbiology.proteinAmyloid Precursor Protein Secretases5' Untranslated RegionsAmyloid precursor protein secretase
researchProduct

Probing ensemble polymorphism and single aggregate structural heterogeneity in insulin amyloid self-assembly.

2020

Ensembles of protein aggregates are characterized by a nano- and micro-scale heterogeneity of the species. This diversity translates into a variety of effects that protein aggregates may have in biological systems, both in connection to neurodegenerative diseases and immunogenic risk of protein drug products. Moreover, this naturally occurring variety offers unique opportunities in the field of protein-based biomaterials. In the above-mentioned fields, the isolation and structural analysis of the different amyloid types within the same ensemble remain a priority, still representing a significant experimental challenge. Here we address such complexity in the case of insulin for its relevance…

Fluorescence-lifetime imaging microscopyAmyloidFIBRIL POLYMORPHISMPHASOR APPROACHSURFACESpheruliteProtein ConformationSurface Propertiesmedicine.medical_treatmentBETATHIOFLAVIN-T FLUORESCENCE02 engineering and technologyMicro-FTIRProtein aggregation010402 general chemistryFibril01 natural sciencesFluorescence lifetime imagingBiomaterialsProtein AggregatesColloid and Surface ChemistryBINDINGHuman insulinmedicineInsulinParticle SizeSECONDARY STRUCTURESPHERULITESChemistryInsulinAmyloidosisOptical ImagingMICROSCOPY021001 nanoscience & nanotechnologymedicine.disease0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsBiopharmaceuticalMicroscopy FluorescenceAmyloid structureVisible and subvisible particlesBiophysicsThioflavin TSelf-assemblyHeterogeneity0210 nano-technologyInfrared microscopyPROTEIN AGGREGATIONJournal of colloid and interface science
researchProduct

Phasor-FLIM analysis of Thioflavin T self-quenching in Concanavalin amyloid fibrils

2020

The formation of amyloid structures has traditionally been related to human neurodegenerative pathologies and, in recent years, the interest in these highly stable nanostructures was extended to biomaterial sciences. A common method to monitor amyloid growth is the analysis of Thioflavin T fluorescence. The use of this highly selective dye, diffused worldwide, allows mechanistic studies of supramolecular assemblies also giving back important insight on the structure of these aggregates. Here we present experimental evidence of self-quenching effect of Thioflavin T in presence of amyloid fibrils. A significant reduction of fluorescence lifetime of this dye which is not related to the propert…

Fluorescence-lifetime imaging microscopyAmyloidFLIMHistologyAmyloid02 engineering and technologyProtein aggregationprotein aggregation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineself-quenchingmental disordersamyloid fibrilConcanavalin Afluorescence lifetimeHumansBenzothiazolesInstrumentationFluorescent DyesInclusion BodiesQuenching (fluorescence)biologyStaining and LabelingChemistryOptical ImagingPhasorNeurodegenerative Diseases030206 dentistry021001 nanoscience & nanotechnologyFluorescenceSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Medical Laboratory TechnologyMicroscopy FluorescenceConcanavalin APhasorbiology.proteinBiophysicsThioflavin TThioflavinamyloid fibrils Concanavalin A FLIM fluorescence lifetime Phasor protein aggregation self-quenching Thioflavin TAnatomy0210 nano-technology
researchProduct